Literature DB >> 27472230

HER2 Immunohistochemistry-Guided Targeted Fluorescence In Situ Hybridization Analysis Does Not Help Identify Intratumoral Heterogeneity in Breast Cancer.

H Evin Gulbahce1, Rachel Factor1, Katherine Geiersbach1, Erinn Downs-Kelly1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27472230     DOI: 10.5858/arpa.2016-0015-LE

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


× No keyword cloud information.
  1 in total

1.  Intratumor heterogeneity defines treatment-resistant HER2+ breast tumors.

Authors:  Inga H Rye; Anne Trinh; Anna B Saetersdal; Daniel Nebdal; Ole Christian Lingjaerde; Vanessa Almendro; Kornelia Polyak; Anne-Lise Børresen-Dale; Åslaug Helland; Florian Markowetz; Hege G Russnes
Journal:  Mol Oncol       Date:  2018-09-21       Impact factor: 6.603

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.